SCHEMBL9734394

SCHEMBL9734394

COC(=O)c1ccccc1CNCc1cn(Cc2ccccc2)c2cc(Cl)c(OC)cc12

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
TP53 P04637 2/20 0.47
PLA2G2A P14555 3/20 0.47
S1PR2 O95136 2/20 0.45
ICMT O60725 1/20 0.44
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
POLB P06746 2/20 0.43
P2RX7 Q99572 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
PDE10A Q9Y233 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9734393 0.88 MAPT (0.51) MAPTTP53PLA2G2AS1PR2ICMT
SCHEMBL9733317 0.82 P2RX7 (0.52) MAPTPLA2G2AS1PR2ICMTP2RX7
SCHEMBL9732562 0.78 ICMT (0.48) MAPTPLA2G2AICMTP2RX7LMNA
SCHEMBL9732159 0.76 KDM4E (0.48) MAPTTP53PLA2G2AICMTPOLB
SCHEMBL9731975 0.74 P2RX7 (0.54) MAPTTP53PLA2G2AP2RX7LMNA
SCHEMBL9732575 0.74 ALDH1A1 (0.49) MAPTTP53PLA2G2APOLBP2RX7
SCHEMBL9733154 0.72 PLA2G2A (0.50) TP53PLA2G2AMTNR1AMTNR1BP2RX7
SCHEMBL9733084 0.72 P2RX7 (0.52) MAPTTP53PLA2G2AICMTP2RX7
SCHEMBL5131095 0.72 PLA2G2A (0.52) MAPTTP53PLA2G2AMTNR1AMTNR1B
SCHEMBL9732157 0.71 PLA2G2A (0.49) MAPTTP53PLA2G2AMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007829-A1 INDOLE-3-METHANAMINES USEFUL AS ANTI-DIABETIC, ANTI-OBESITY AND ANTI-ATHEROSCLEROTIC AGENTS THE UPJOHN COMPANY (US) 1992-05-14 WO disclosed